Accendra Health Inc. ACH
Medical Specialities · data as of November 13, 2026
Accendra Health Inc. (ACH) is a healthcare company listed in the US with a market value of about $10M. In the twelve months to September 30, 2026 it had revenue of $2.6B and net income of -$172M, a net margin of -6.7%.
Its overall Stock Analiz score is 0.6 out of 5 (weak). The strongest part is value (1/5); the weakest is future growth (0/5).
Key numbers: 5-year revenue growth of -20% a year, a 5-year average ROIC of 3%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 725% above the current price.
About Accendra Health
Accendra Health is listed in the US and classified in medical specialities. Revenue went from $9.4B in 2014 to $2.8B in 2025, a decline of about 10.6% a year. It was profitable in 5 of the last 10 years in our data.
Score: 0.6 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.6B | $2.8B | $2.7B | $2.6B | $10.0B | $9.8B | $8.5B | $9.2B | $9.4B | $9.3B | $9.7B |
| Net income | -$172M | -$1.1B | -$363M | -$41M | $22M | $222M | $30M | -$62M | -$437M | $73M | $109M |
| Free cash flow | -$199M | -$293M | -$9M | $568M | $167M | $83M | $289M | $124M | $71M | $22M | $167M |
| EPS (diluted) | $-2.25 | $-14.31 | $-4.73 | $-0.53 | $0.29 | $2.94 | $0.47 | $-1.03 | $-7.28 | $1.20 | $1.76 |
| Net margin | -6.7% | -39.9% | -13.5% | -1.6% | 0.2% | 2.3% | 0.4% | -0.7% | -4.6% | 0.8% | 1.1% |
| ROIC | — | 1.3% | -6.7% | 2.3% | 3.0% | 14.1% | 8.6% | 2.6% | -14.8% | 3.6% | 8.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Accendra Health stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 725% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Accendra Health pay a dividend?
Not currently.
Is Accendra Health a good stock to buy?
We do not give buy or sell advice. Accendra Health scores 0.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.